Enlivex Therapeutics Ltd. — Report Publication Announcement 2019

Nov 18, 2019

_________ false

�������� ��������� ��"�	2 380
ENLIVEX THERAPEUTICS LTD
Corporation no: 514716489	12568
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	18/11/2019
	www.isa.gov.il			www.tase.co.il				Reference:	2019-02-099114	Time of broadcast: 14:30 14:29:28

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on_________

pressrelease111619_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1	Date of revision of form structure: 29/10/2019
Address: Einstein 14 , NES-ZIONA 7403618   , ISRAEL Tel: 02-6708072 , Fax: 02-6708070
E-mail address: shachar@enlivexpharm.com   Company site: www.enlivex.com
Previous names of reporting entity:
Name of the Signatory: SHLOSBERGER SHACHAR Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company: Enlivex thetraputics R&D
Address: Nachal Dan 19 , Qiryat Uno 61580 Telephone: 054-4617610 Facsimile: - E-mail: shachar@ramdor.co.il 2
ISRAEL